239 related articles for article (PubMed ID: 37447728)
1. Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.
Gracia DI; Ortiz M; Candela T; Iáñez E; Sánchez RM; Díaz C; Azorín JM
Sensors (Basel); 2023 Jun; 23(13):. PubMed ID: 37447728
[TBL] [Abstract][Full Text] [Related]
2. Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique.
Lechien JR; Saussez S
Ear Nose Throat J; 2024 Jun; 103(1_suppl):115S-119S. PubMed ID: 36219733
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.
Schmidt F; Azar C; Goektas O
Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171
[TBL] [Abstract][Full Text] [Related]
4. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
[TBL] [Abstract][Full Text] [Related]
5. [Loss of smell, a preliminary indicator of COVID-19].
Waizel-Haiat S; Waizel-Bucay J
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
Las Casas Lima MH; Cavalcante ALB; Leão SC
Braz J Otorhinolaryngol; 2022; 88(5):794-802. PubMed ID: 33965353
[TBL] [Abstract][Full Text] [Related]
7. Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.
Ojha P; Dixit A
Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):462-473. PubMed ID: 35090056
[TBL] [Abstract][Full Text] [Related]
8. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.
Shahbaz MA; De Bernardi F; Alatalo A; Sachana M; Clerbaux LA; Muñoz A; Parvatam S; Landesmann B; Kanninen KM; Coecke S
Cells; 2022 Sep; 11(19):. PubMed ID: 36230989
[TBL] [Abstract][Full Text] [Related]
10. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
[TBL] [Abstract][Full Text] [Related]
11. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
[TBL] [Abstract][Full Text] [Related]
12. Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study.
Denis F; Septans AL; Periers L; Maillard JM; Legoff F; Gurden H; Moriniere S
J Med Internet Res; 2021 May; 23(5):e29583. PubMed ID: 34003765
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
[TBL] [Abstract][Full Text] [Related]
14. [The alleged mechanisms of olfactory disorders in the new coronavirus infection].
Lashch NY; Yunyaev AR; Evsyukova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):7-11. PubMed ID: 36843453
[TBL] [Abstract][Full Text] [Related]
15. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
[TBL] [Abstract][Full Text] [Related]
16. The temporal course of COVID-19 anosmia and relation to other clinical symptoms.
Altundag A; Saatci O; Sanli DET; Duz OA; Sanli AN; Olmuscelik O; Temirbekov D; Kandemirli SG; Karaaltin AB
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1891-1897. PubMed ID: 33237475
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and anosmia: The story so far.
Meng X; Pan Y
Ear Nose Throat J; 2024 May; 103(5):NP312-NP320. PubMed ID: 34587819
[TBL] [Abstract][Full Text] [Related]
18. A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.
Hirano K; Tanaka Y; Kamimura S; Suzaki I; Suzuki E; Kobayashi H
Am J Case Rep; 2022 Sep; 23():e936496. PubMed ID: 36089753
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of olfactory dysfunction persistence after COVID-19: a prospective study.
Bianco MR; Ralli M; Minni A; Greco A; de Vincentiis M; Allegra E
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1042-1048. PubMed ID: 35179771
[TBL] [Abstract][Full Text] [Related]
20. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
